These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8839237)

  • 1. Expression of E-cadherin in skin carcinomas.
    Tada H; Hatoko M; Muramatsu T; Shirai T
    J Dermatol; 1996 Feb; 23(2):104-10. PubMed ID: 8839237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of desmoglein I and plakoglobin in skin carcinomas.
    Tada H; Hatoko M; Tanaka A; Kuwahara M; Muramatsu T
    J Cutan Pathol; 2000 Jan; 27(1):24-9. PubMed ID: 10660128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered distribution of 1-2B7B antigen in basal cell carcinoma, squamous cell carcinoma and Bowen's disease.
    Zhang XM; Horiguchi Y; Ueda M; Yoshiki T; Imamura S
    J Dermatol Sci; 1992 Jan; 3(1):46-55. PubMed ID: 1591227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed carcinoma in situ: an immunohistochemical study.
    Peralta OC; Barr RJ; Romansky SG
    J Cutan Pathol; 1983 Oct; 10(5):350-8. PubMed ID: 6313778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin expression in skin tumors using an AMeX immunohistostaining method.
    Koseki S; Ansai S; Aoki T; Hozumi Y; Mitsuhashi Y; Kondo S
    J Dermatol; 2000 May; 27(5):307-11. PubMed ID: 10875196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
    Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of inducible nitric oxide synthase in skin cancers.
    Kagoura M; Matsui C; Toyoda M; Morohashi M
    J Cutan Pathol; 2001 Oct; 28(9):476-81. PubMed ID: 11553314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pagetoid Bowen's disease vs. extramammary Paget's disease.
    Raiten K; Paniago-Pereira C; Ackerman AB
    J Dermatol Surg; 1976 Mar; 2(1):24-5. PubMed ID: 181411
    [No Abstract]   [Full Text] [Related]  

  • 9. Bowen's disease, Paget's disease, and malignant melanoma in situ.
    Rosen L; Amazon K; Frank B
    South Med J; 1986 Apr; 79(4):410-3. PubMed ID: 2422766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin tumors.
    Traub EF
    Cutis; 1976 Sep; 18(3):366-72. PubMed ID: 189972
    [No Abstract]   [Full Text] [Related]  

  • 11. Three-dimensional architecture of epithelial skin tumors: an application of epidermal separation.
    Kimura S
    J Dermatol; 1981 Feb; 8(1):13-9. PubMed ID: 6262393
    [No Abstract]   [Full Text] [Related]  

  • 12. RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin.
    Takahashi H; Iizuka H; Nakashima M; Wada T; Asano K; Ishida-Yamamoto A; Watanabe T
    J Dermatol Sci; 2001 Jun; 26(2):140-4. PubMed ID: 11378331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premalignant lesions of the anal margin.
    Beck DE; Fazio VW
    South Med J; 1989 Apr; 82(4):470-4. PubMed ID: 2539650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Skin cancer and precancerosis].
    Ikeda S; Suzuki T; Kiyohara N; Sasaki T; Hayashibara Y
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1755-66. PubMed ID: 2994574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors.
    Tanese K; Emoto K; Kubota N; Fukuma M; Sakamoto M
    J Dermatol; 2018 Oct; 45(10):1181-1186. PubMed ID: 30035333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-existence of extramammary Paget's disease and Bowen's disease of vulva.
    Goyal T; Varshney A; Solanki R
    Indian J Dermatol Venereol Leprol; 2014; 80(6):530-3. PubMed ID: 25382511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical distinction of Paget's disease from Bowen's disease and superficial spreading melanoma with the use of monoclonal cytokeratin antibodies.
    Shah KD; Tabibzadeh SS; Gerber MA
    Am J Clin Pathol; 1987 Dec; 88(6):689-95. PubMed ID: 2446491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
    Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
    Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Skin malignant tumor. High-risk groups].
    Ishihara K
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2667-71. PubMed ID: 2820311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistology is valuable in distinguishing between Paget's disease, Bowen's disease and superficial spreading malignant melanoma.
    Reed W; Oppedal BR; Eeg Larsen T
    Histopathology; 1990 Jun; 16(6):583-8. PubMed ID: 1695889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.